{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:05:21Z","timestamp":1772751921763,"version":"3.50.1"},"reference-count":21,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["AIAAMC"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec><jats:title>Introduction:<\/jats:title><jats:p>Benign Prostatic Hyperplasia (BPH) is a benign tumor in males, which is histopathologically known with an increase of epithelial cells and prostatic stroma. Androgens, estrogens, stroma-epithelial interactions, growth factors, and chronic inflammation play a key role in the occurrence of BPH. Chronic inflammation in BPH is characterized by excessive expression of COX-2, which will trigger the expression of Bcl-2 anti-apoptotic protein. Dayak onion (Eleutherine Americana Merr) is a typical Kalimantan plant that is known as the treatment for prostate disease. This plant contains flavonoids which can inhibit the COX-2 enzyme thus causing a reduction in the production of prostaglandin E2.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>This research was experimental research computationally and in vitro laboratory experimental research to determine COX-2 inhibitory activity by ethanol extracts of Dayak onion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result and Discussion:<\/jats:title><jats:p>In in silico flavonoid, it was strongly related to COX-2 receptor on the active side of TYR371. Thus, it had the potential to inhibit COX-2. COX-2 inhibitor would cause BCL-2 to be inactive so that apoptosis occurr in BPH. In the in vitro research using human whole blood assay, the Dayak Onion bulb ethanol extract had IC50 COX-2 of 40.57 ng\/ml and IC50 COX-1 of 364.89 ng\/ml. Therefore, the ratio of IC50 COX-2 to IC50 COX-1 was 0.11.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Ethanol extract of Dayak onion bulb has an inhibitory activity against COX-2. Thus, it has a potential of being an innovation for BPH treatment. Patient Summary: A healthy male, age 25-35 years old (history taking, physical and laboratory examination), and not using NSAIDs for the past 2 weeks.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871523019666200304121702","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T13:30:17Z","timestamp":1583328617000},"page":"68-74","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["In Silico and In Vitro Study: COX-2 Inhibition by Ethanol Extract of Dayak Onion Bulb (Eleutherine Americana Merr) as Treatment Innovation of Benign Prostatic Hyperplasia (BPH)"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1598-4722","authenticated-orcid":true,"given":"Hendra","family":"Sutapa","sequence":"first","affiliation":[{"name":"Doctoral Program of Medical Science, Faculty of Medicine, Brawijaya University, Malang, East Java,Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mochammad Aris","family":"Widodo","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Brawijaya University, Malang, East Java,Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2640-2246","authenticated-orcid":true,"given":"Basuki Bambang","family":"Purnomo","sequence":"additional","affiliation":[{"name":"Department of Urology, Faculty of Medicine, Brawijaya University, Malang, East Java,Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0982-4383","authenticated-orcid":true,"given":"Doddy M.","family":"Soebadi","sequence":"additional","affiliation":[{"name":"Department of Urology, Faculty of Medicine, Airlangga University, Surabaya, East Java,Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0702-1173","authenticated-orcid":true,"given":"Edvin Prawira","family":"Negara","sequence":"additional","affiliation":[{"name":"4Department of Urology, Faculty of Medicine, Brawijaya University, Malang, East Java,Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1016\/B978-1-4160-6911-9.00091-8","author":"Roehrborn C.G.","year":"2012","unstructured":"Roehrborn C.G.; Benign prostatic hyperplasia etiology, pathophysiology, epidemiology, and natural history of prostatic hyperplasia Campbell-Walsh Urology 2012,2570-2610","journal-title":"Benign prostatic hyperplasia etiology, pathophysiology, epidemiology, and natural history of prostatic hyperplasia Campbell-Walsh Urology"},{"key":"ref=2","author":"Cooperberg M.R.","year":"2013","unstructured":"Cooperberg M.R.; Presti J.C.; Shinohara K.; Carroll P.R.; McGraw Neoplasm of the prostate gland Smith 2013","journal-title":"McGraw Neoplasm of the prostate gland Smith"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.eururo.2006.12.011","volume":"51","author":"Kramer G.","year":"2007","unstructured":"Kramer G.; Mitteregger D.; Marberger M.; Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 2007,51(5),1202-1216","journal-title":"Eur Urol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.eururo.2007.06.038","volume":"52","author":"Sciarra A.","year":"2007","unstructured":"Sciarra A.; Di Silverio F.; Salciccia S.; Autran Gomez A.M.; Gentilucci A.; Gentile V.; Inflammation and chronic prostatic diseases: evidence for a link? Eur Urol 2007,52(4),964-972","journal-title":"Eur Urol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ucl.2007.09.012","volume":"35","author":"Nickel J.C.","year":"2008","unstructured":"Nickel J.C.; Inflammation and benign prostatic hyperplasia. Urol Clin North Am 2008,35(1),109-115","journal-title":"Urol Clin North Am"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2011.03.055","volume":"60","author":"De Nunzio C.","year":"2011","unstructured":"De Nunzio C.; Kramer G.; Marberger M.; Montironi R.; Nelson W.; Schr&#xF6;der F.; Sciarra A.; Tubaro A.; The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol 2011,60(1),106-117","journal-title":"Eur Urol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0090-4295(00)00674-9","volume":"56","author":"Kirschenbaum A.","year":"2000","unstructured":"Kirschenbaum A.; Klausner A.P.; Lee R.; Unger P.; Yao S.; Liu X.H.; Levine A.C.; Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate. Urology 2000,56(4),671-676","journal-title":"Urology"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1677\/JOE-06-0181","volume":"195","author":"Wu Q.","year":"2007","unstructured":"Wu Q.; Zhou Y.; Chen L.; Shi J.; Wang C.Y.; Miao L.; Klocker H.; Park I.; Lee C.; Zhang J.; Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2. J Endocrinol 2007,195(1),89-94","journal-title":"J Endocrinol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"26565","DOI":"10.1074\/jbc.M413056200","volume":"280","author":"Shao J.","year":"2005","unstructured":"Shao J.; Jung C.; Liu C.; Sheng H.; Prostaglandin E2 Stimulates the &#x3B2;-catenin\/T cell factor-dependent transcription in colon cancer. J Biol Chem 2005,280(28),26565-26572","journal-title":"J Biol Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4111\/kju.2011.52.4.253","volume":"52","author":"Kim B.H.","year":"2011","unstructured":"Kim B.H.; Kim C.I.; Chang H.S.; Choe M.S.; Jung H.R.; Kim D.Y.; Park C.H.; Cyclooxygenase-2 overexpression in chronic inflammation associated with benign prostatic hyperplasia: Is it related to apoptosis and angiogenesis of prostate cancer? Korean J Urol 2011,52(4),253-259","journal-title":"Korean J Urol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.proche.2014.12.032","volume":"13","author":"Insanu M.","year":"2014","unstructured":"Insanu M.; Kusmardiyani S.; Hartati R.; Recent studies on phytochemicals and pharmacological effects of Eleutherine americana Merr. Procedia Chem 2014,13,221-228","journal-title":"Procedia Chem"},{"key":"ref=12","first-page":"161","volume":"24","author":"Febrinda AE.","year":"2013","unstructured":"Febrinda AE.; Astawan M.; Wresdiyati T.; Yuliana ND.; Kapasitas antioksidan dan inhibitor alfa glukosidase ekstrak umbi bawang Dayak J Teknol dan Industri Pangan 2013,24(2),161-166","journal-title":"Kapasitas antioksidan dan inhibitor alfa glukosidase ekstrak umbi bawang Dayak J Teknol dan Industri Pangan"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1254\/jphs.CRJ04003X","volume":"96","author":"Kim H.P.","year":"2004","unstructured":"Kim H.P.; Son K.H.; Chang H.W.; Kang S.S.; Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci 2004,96(3),229-245","journal-title":"J Pharmacol Sci"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"Trott O.","year":"2010","unstructured":"Trott O.; Olson A.J.; AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010,31(2),455-461","journal-title":"J Comput Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1021\/ci049885e","volume":"45","author":"Wolber G.","year":"2005","unstructured":"Wolber G.; Langer T.; LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model 2005,45(1),160-169","journal-title":"J Chem Inf Model"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.7326\/0003-4819-132-2-200001180-00008","volume":"132","author":"Feldman M.","year":"2000","unstructured":"Feldman M.; McMahon A.T.; Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity? Ann Intern Med 2000,132(2),134-143","journal-title":"Ann Intern Med"},{"key":"ref=17","first-page":"1705","volume":"271","author":"Patrignani P.","year":"1994","unstructured":"Patrignani P.; Panara M.R.; Greco A.; Fusco O.; Natoli C.; Iacobelli S.; Cipollone F.; Ganci A.; Cr&#xE9;minon C.; Maclouf J.; Patrono C.; Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther 1994,271(3),1705-1712","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1046\/j.0306-5251.2001.01533.x","volume":"53","author":"Blain H.","year":"2002","unstructured":"Blain H.; Boileau C.; Lapicque F.; N&#xE9;d&#xE9;lec E.; Loeuille D.; Guillaume C.; Gaucher A.; Jeandel C.; Netter P.; Jouzeau J.Y.; Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use. Br J Clin Pharmacol 2002,53(3),255-265","journal-title":"Br J Clin Pharmacol"},{"key":"ref=19","first-page":"409","volume":"12","author":"Arthamin M.Z.","year":"2004","unstructured":"Arthamin M.Z.; Handono K.; Widodo M.A.; Selektivitas hambatan flavonoid fraksi n-butanol ekstrak daun ungu (Graptophyllum pictum (L.) Griif.) terhadap isoenzim siklooksigenase. Madjalah Kedokt Indones 2004,12(10),409-416","journal-title":"Madjalah Kedokt Indones"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/rheumatology\/38.8.779","volume":"38","author":"Brooks P.","year":"1999","unstructured":"Brooks P.; Emery P.; Evans J.F.; Fenner H.; Hawkey C.J.; Patrono C.; Smolen J.; Breedveld F.; Day R.; Dougados M.; Ehrich E.W.; Gijon-Ba&#xF1;os J.; Kvien T.K.; Van Rijswijk M.H.; Warner T.; Zeidler H.; Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. Rheumatology (Oxford) 1999,38(8),779-788","journal-title":"Rheumatology (Oxford)"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.20473\/jvhs.V2.I2.2018.51-55","volume":"2","author":"Paramita S.","year":"2019","unstructured":"Paramita S.; Nuryanto M.; Anti-inflammatory activity of bawang dayak (Eleutherine bulbosa (mill Urb)) Ethanol bulb extracts J Vocat Health Stud 2019,2(2),51","journal-title":"Anti-inflammatory activity of bawang dayak (Eleutherine bulbosa (mill Urb)) Ethanol bulb extracts J Vocat Health Stud"}],"container-title":["Anti-Inflammatory &amp; Anti-Allergy Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/179923","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.eurekaselect.com\/179923\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/eurekaselect.com\/article\/download\/179923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T15:44:25Z","timestamp":1722527065000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/179923\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871523019666200304121702","relation":{},"ISSN":["1871-5230"],"issn-type":[{"value":"1871-5230","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-11-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}